Lycopene for heart and bone health during menopause? Original paper
In this randomized controlled trial, supplementation with lycopene improved lycopene levels and markers of bone turnover but also increased triglyceride levels in menopausal participants.
This Study Summary was published on August 23, 2022.
Background
The study
This 6-month multicenter randomized controlled trial included 100 menopausal women (average age of 50) who took either a lycopene supplement (LycoRed, 8 mg; 57 participants) or a placebo (43 participants).
Blood samples were collected to evaluate changes in lycopene levels, lipid profile (i.e., triglycerides, cholesterols), and bone turnover biomarkers such as propeptide of Type I collagen (P1NP; an indicator of bone formation) and C-terminal telopeptide of Type I collagen (CTX; an indicator of bone resorption).
The results
Supplementation with lycopene increased lycopene levels, triglycerides, and P1NP, compared to placebo.
Note
Diet and physical activity were not monitored during the intervention.
In addition to the 2 mg of lycopene per capsule, the LycoRed supplement contained 7.5 mg of zinc and 35 micrograms of selenium, but so did the placebo. The supplement and placebo were provided by the company that produces the supplement.
Get free weekly updates on what’s new at Examine.
This Study Summary was published on August 23, 2022.
References
- ^Walallawita US, Wolber FM, Ziv-Gal A, Kruger MC, Heyes JAPotential Role of Lycopene in the Prevention of Postmenopausal Bone Loss: Evidence from Molecular to Clinical Studies.Int J Mol Sci.(2020-Sep-27)
- ^Mazidi M, Ferns GA, Banach MA high consumption of tomato and lycopene is associated with a lower risk of cancer mortality: results from a multi-ethnic cohort.Public Health Nutr.(2020-06)
- ^Agarwal S, Rao AVTomato lycopene and its role in human health and chronic diseases.CMAJ.(2000-Sep-19)